Search Results - "Ruiz Guiñazú, J"

P363 Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on pneumococcal disease by Hausdorff, W, Mrkvan, T, Moreira, M, Ruiz Guiñazú, J, Borys, D

Get full text

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S by Sadoff, Jerald, Gray, Glenda, Vandebosch, An, Cárdenas, Vicky, Shukarev, Georgi, Grinsztejn, Beatriz, Goepfert, Paul A, Truyers, Carla, Van Dromme, Ilse, Spiessens, Bart, Vingerhoets, Johan, Custers, Jerome, Scheper, Gert, Robb, Merlin L, Treanor, John, Ryser, Martin F, Barouch, Dan H, Swann, Edith, Marovich, Mary A, Neuzil, Kathleen M, Corey, Lawrence, Stoddard, Jeffrey, Hardt, Karin, Ruiz-Guiñazú, Javier, Le Gars, Mathieu, Schuitemaker, Hanneke, Van Hoof, Johan, Struyf, Frank, Douoguih, Macaya

“…The randomized trial assessing the efficacy of a single injection of the Ad26.COV2.S showed 56.3% vaccine efficacy beginning 14 days after injection and 52.9%…”
Get full text

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial by Kilpi, T.M., Jokinen, J., Puumalainen, T., Nieminen, H., Ruokokoski, E., Rinta-Kokko, H., Traskine, M., Lommel, P., Moreira, M., Ruiz-Guinazu, J., Borys, D., Schuerman, L., Palmu, A.A.

“…•First European trial on effectiveness of a PCV against pneumonia in children.•PHiD-CV10 reduced any hospital-diagnosed pneumonia by 27%.•Reduction of…”
Get full text